- Home
- MEIP vs WKSP Comparison
MEIP vs WKSP Comparison
Compare MEIP & WKSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MEIP
- WKSP
- Stock Information
- Founded
- MEIP 2000
- WKSP 2003
- Country
- MEIP United States
- WKSP United States
- Employees
- MEIP N/A
- WKSP N/A
- Industry
- MEIP Biotechnology: Pharmaceutical Preparations
- WKSP Auto Parts:O.E.M.
- Sector
- MEIP Health Care
- WKSP Consumer Discretionary
- Exchange
- MEIP Nasdaq
- WKSP Nasdaq
- Market Cap
- MEIP 13.3M
- WKSP 14.6M
- IPO Year
- MEIP 2003
- WKSP N/A
- Fundamental
- Price
- MEIP $2.80
- WKSP $3.03
- Analyst Decision
- MEIP Hold
- WKSP Strong Buy
- Analyst Count
- MEIP 1
- WKSP 3
- Target Price
- MEIP N/A
- WKSP $12.83
- AVG Volume (30 Days)
- MEIP 13.3K
- WKSP 177.5K
- Earning Date
- MEIP 05-13-2025
- WKSP 08-12-2025
- Dividend Yield
- MEIP N/A
- WKSP N/A
- EPS Growth
- MEIP N/A
- WKSP N/A
- EPS
- MEIP N/A
- WKSP N/A
- Revenue
- MEIP N/A
- WKSP $10,211,747.00
- Revenue This Year
- MEIP N/A
- WKSP $159.92
- Revenue Next Year
- MEIP N/A
- WKSP $68.25
- P/E Ratio
- MEIP N/A
- WKSP N/A
- Revenue Growth
- MEIP 33.76
- WKSP 407.96
- 52 Week Low
- MEIP $1.46
- WKSP $2.44
- 52 Week High
- MEIP $4.10
- WKSP $12.00
- Technical
- Relative Strength Index (RSI)
- MEIP 78.43
- WKSP 50.10
- Support Level
- MEIP $2.21
- WKSP $2.80
- Resistance Level
- MEIP $2.95
- WKSP $3.14
- Average True Range (ATR)
- MEIP 0.15
- WKSP 0.28
- MACD
- MEIP 0.05
- WKSP -0.01
- Stochastic Oscillator
- MEIP 81.48
- WKSP 30.00
About MEIP MEI Pharma Inc.
MEI Pharma Inc is focused on the clinical development of novel therapies for cancer. The company's clinical drug candidate includes Pracinostat, an orally available histone deacetylase inhibitor for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome. Its clinical development portfolio also includes Zandelisib, an oral inhibitor of phosphatidylinositide 3-kinase delta for the treatment of patients with recurrent chronic lymphocytic leukemia or follicular non-Hodgkin's lymphoma; and ME-344, an isoflavone-based mitochondrial inhibitor for the treatment of HER2-negative breast cancer and Pracinostat, an oral histone deacetylase inhibitor. Geographically, all the business activities function through the region of the United States.
About WKSP Worksport Ltd.
Worksport Ltd through its subsidiaries, designs, develops, manufactures, and owns the IP on a variety of tonneau covers, solar integrations, and NP (Non-Parasitic), Hydrogen-based true green energy solutions for the sustainable, clean energy, and automotive industries. The company's product includes soft vinyl tonneau covers and hard aluminum tonneau covers. It operates in two reporting segments for financial reporting purposes: Hard Tonneau Covers and Soft Tonneau Covers. Geographically, the company operates in Canada, United States and Other Countries.